Gene Query: HIST1H2BB

Dataset Description Geneva Score
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 135.7
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 90.58
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 90.58
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 81.85
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 75.46
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 73.45
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 65.68
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 62.23
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 60.64
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 58.69
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 56.74
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 56.74
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 52.82
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 50.26
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 49.32
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 49.32
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 48.98
Retinoic acid suppresses MYB in adenoid cystic carcinoma 48.98
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 45.61
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 43.68
Differentially expressed genes post knock down of lincDUSP26 43.53
Endothelial gene expression analysis 40.33
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 40.33
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 39.83
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 38.68
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 37.7
Expression and functions of long noncoding RNAs during human T helper cell differentiation 37.09
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 37.06
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 36.17
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 35.28
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 34.73
RNA-seq of resting and activated CD4+ T cells +-JQ1 34.52
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 32.2
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 32.2
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 32.16
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 31.85
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 31.1
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 31.1
Differentiation enhances Zika virus infection in neuronal brain cells 30.13
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 28.99
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 28.94
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 28.41
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 27.96
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  26.93
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 26.41
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 25.13
Widespread intronic polyadenylation diversifies immune cell transcriptomes 24.52
MYCi361 regulates MYC target genes 23.18
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 22.78
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 22.74
circRNA profile in hypopharyngeal cancer 22.14
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 22.12
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 22.11
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 22.02
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 22.02
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 21.67
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 21.49
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 21.02
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 20.77
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 20.64
Ribosomal footprinting of CN34-Parental and CN34-LM1a 20.02
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 19.51
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 18.75
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 18.75
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 18.39
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 18.39
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 17.87
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 17.83
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 17.64
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 17.4
Oncogenic MYC induces a dependency on the spliceosome in human cancer 17.34
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 17.31
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 17.31
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 16.98
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 16.75
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 16.75
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 16.12
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 15.87
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 15.74
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 15.5
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 15.37
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 15.06
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 14.99
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 14.99
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 13.53
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 13.46
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 13.4
Ribosomal footprinting of MDA-Parental and MDA-LM2 13.36
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 13.27
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 13.27
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 13.27
p63 controls the enhancer landscape during keratinocyte differentiation 13.26
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 13.21
Hypoxic transcriptome of SQ20B human head and neck cancer cells 13.11
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 13.07
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 13.06
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 12.7
Genome-wide mapping of TEL-AML1 targets in acute leukemia 12.16
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 11.87
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 11.84
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 11.82
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 11.7
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.53
Landscape and variation of RNA secondary structure across the human transcriptome 11.34
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 11.27
Gene induction by the USP6 oncogene in response to interferon 11.24
Short and Long RNA sequencing of human mature erythrocytes 11.21
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 11.06
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 10.7
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 10.65
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 10.64
Cajal bodies are linked to genome conformation [RNA-Seq] 10.41
Cajal bodies are linked to genome conformation 10.41
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 10.37
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 10.27
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 10.26
Total RNA-seq in ALL-SIL upon JQ1 inhibition 10.22
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 9.89
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 9.89
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 9.89
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 9.87
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 9.74
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 9.69
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 9.63
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 9.63
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 9.57
Cellular response to hepatitis E virus (HEV) infection 9.57
Studying the selectivity of a small molecule Synucleozid on transcriptome 9.53
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 9.49
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 9.49
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 9.12
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 8.99
CircRNAome diversity in human mature B-cells, T-cells and monocytes 8.85
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 8.83
Landscape of H3K4me3 in human CD19 cells 8.75
RIG-I and MDA5 fRIP during KSHV lytic reactivation 8.66
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 8.51
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 8.46
RNA-Seq from early time points in the kidney differentiation protocol 8.35
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 8.31
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 8.15
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 7.83
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 7.83
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 7.82
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 7.74
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 7.72
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 7.72
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.48
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 7.48
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 7.48
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 7.45
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 7.45
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 7.43
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 7.39
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.24
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 7.23
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 7.19
RNA sequencing with KSHV infection and enrichment for circular RNAs 7.05
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 7.04
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 7.04
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 6.78
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 6.74
Gene expression profiling of human and murine in vitro muscle differentiation 6.74
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 6.73
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 6.59
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 6.59
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 6.59
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 6.46
BCL11B 6.41
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.17
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.17
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 6.16
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 6.11
Total RNA-seq in ALL-SIL upon TLX1 knockdown 6.1
Integrin signaling regulates YAP/TAZ to control skin homeostasis 6.06
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 6.0
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 5.87
Zika infected neural stem cells 5.78
Transcriptome analysis of Zika infected neural stem cells 5.78
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 5.71
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 5.7
Effect of BB608 on Gene Expression in HNSCC Cell Line 5.65
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 5.56
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 5.54
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 5.51
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 5.23
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 5.23
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 5.23
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 5.15
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 5.13
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 5.07
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 5.06
Differential responses of human fetal brain neural stem cells to Zika virus infection 5.04
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 5.0
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.93
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 4.92
RNA-Seq with and without RNase treatment in PCa cell lines 4.89
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 4.77
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 4.76
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 4.76
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 4.7
The interplay between SOX4 and SMAD3 in the context of breast cancer 4.66
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 4.58
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 4.58
MYCi975 regulates MYC target genes 4.54
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 4.52
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 4.52
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 4.48
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.37
6mer seed toxicity in tumour suppressive microRNAs 4.36
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 4.33
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 4.3
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 4.21
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 4.17
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 4.13
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 3.96
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 3.96
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 3.96
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 3.92
Transcription elongation regulates genome 3D structure 3.85
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.8
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 3.75
Dynamic reorganization of nuclear architecture during human cardiogenesis 3.75
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.66
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 3.62
Entrectinib Resistance in a Neuroblastoma Xenograft Model 3.41
Gene expression in PANC1 cells treated with Rakicidin 3.41
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 3.3
Genome-wide identification of cancer-specific alternative splicing in circRNA 3.25
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 3.21
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.17
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.17
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 3.08
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 3.08
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 3.07
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 3.06
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.03
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.96
circNFIB suppresses lymphatic metastasis of pancreatic cancer 2.95
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.93
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.93
Transcriptome profiling of 5 human adenocarcinoma cell lines 2.93
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 2.91
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 2.9
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 2.9
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 2.9
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.87
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.8
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.79
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.79
DRB/GRO-Seq -/+ UV 2.77
Universal alternative splicing of noncoding exons 2.76
KSDM1b Role in Ewing Sarcoma 2.67
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 2.64
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 2.63
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.55
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 2.54
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 2.52
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.49
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.43
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 2.42
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.42
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.42
circRNA-sequencing 2.42
RNA polymerase in pre-B-ALL cell lines 2.34
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 2.33
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 2.33
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 2.32
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.3
RNA-seq of cells with TET1 knockout 2.25
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 2.25
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 2.24
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 2.24
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 2.15
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.14
EWS-Fli and LNC regulated genes in comparison to GFP samples 2.14
Gene expression profile in breast cancer cells 2.11
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.11
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.09
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 2.08
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 2.08
TAF1 is critical for AE driven leukemogenesis 2.06
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.06
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 2.03
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 2.03
Tyrosine Kinase Inhibitor Cardiotoxicity 2.03
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 1.93
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 1.91
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.88
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 1.88
TGF-β regulation of miRNA expression in pancreatic cancer 1.83
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.83
RNA-sequencing in irradiated and normal A549 cells. 1.8
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.8
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.8
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 1.73
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.72
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 1.7
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 1.7
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.68
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.68
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 1.66
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.64
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 1.61
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 1.61
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 1.61
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 1.61
BAF controls genome accessibility 1.55
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 1.54
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 1.49
Accurate annotation of human protein-coding small open reading frames 1.48
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 1.47
siRNA-mediated knockdown 1.47
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.44
Loss of CREBBP results in gene expression repression in lymphoma cells 1.44
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 1.42
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.41
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 1.4
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.39
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 1.38
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.37
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 1.33
Developmental stage specific chromosome architecture in human erythroid cells 1.33
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 1.32
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 1.32
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 1.31
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 1.31
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 1.31
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 1.31
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.31
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.31
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 1.3
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 1.29
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.29
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 1.28
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.27
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 1.25
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 1.25
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 1.25
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.24
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.2
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  1.19
Splicing and epigenetic factors jointly regulate epidermal differentiation 1.18
PNET animal model: new insights (II) 1.17
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.17
MHC Transcriptomic landscape at haplotype-specific resolution 1.14
Expression profiling of etoposide-induced senescent cells 1.14
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 1.12
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 1.12
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 1.12
Dynamic 3D chromosomal landscapes in acute leukemia 1.12
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 1.09
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 1.03
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 1.03
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 1.02
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 1.01
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.99
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 0.99
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 0.99
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 0.98
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 0.96
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 0.95
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 0.95
Selective expression of long non-coding RNAs in a breast cancer cell progression model 0.95
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.93
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.92
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.92
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 0.92
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.91
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.91
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.9
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.9
The conserved transcriptional landscapes in human spermatogenesis 0.9
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 0.89
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 0.88
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 0.88
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.88
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.87
The pioneer factor CEBPA modulates vitamin D signaling 0.87
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.86
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 0.86
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 0.86
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 0.85
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.84
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.84
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 0.84
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.83
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 0.83
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 0.8
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.79
Unique features and clinical importance of acute alloreactive immune responses 0.77
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.77
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.77
LIN28A Over-expression RNAseq 0.75
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 0.75
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.75
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 0.74
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 0.74
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.74
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.74
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 0.72
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 0.71
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.71
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 0.71
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.67
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.67
Transcriptomic analysis of frontal fibrosing alopecia 0.67
Global response to chemotherapy-induced apoptosis 0.66
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 0.64
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.63
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.63
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.63
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.62
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 0.58
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.57
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.57
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.57
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.55
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.55
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 0.55
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.54
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.52
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.52
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 0.51
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.5
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 0.5
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.49
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.47
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 0.45
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 0.45
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 0.45
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 0.45
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.42
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.4
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.4
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 0.4
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 0.39
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.38
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 0.37
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 0.37
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.36
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.36
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.36
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 0.35
RNA-seq of primary patient AML samples 0.35
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.34
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 0.34
Identification of long noncoding RNAs in T-ALL cell lines 0.34
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.33
TFAP2C signalling in human fibroblasts 0.33
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.33
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.31
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.31
mRNA-sequencing of breast cancer subtypes and normal tissue 0.3
RNA seq comparison between scrambled and shGRP78 cells 0.28
Positively selected enhancer elements endow tumor cells with metastatic competence 0.28
RNA editing in nascent RNA affects pre-mRNA splicing 0.28
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 0.26
Ribosome profiling upon inhibition of eIF4A 0.25
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.24
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.24
Gene expression activation in CLL mediated by MSCs contact 0.23
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.23
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.23
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.21
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.2
RNAseq of Breast cancer PDX samples 0.19
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.19
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.19
ML29755 RNA-seq data 0.18
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.18
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.17
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.17
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.17
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.17
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.16
Epigenome regulation during epidermal lineage commitment 0.15
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.14
BASP1 modifies the Tamoxifen response 0.14
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.09
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.08
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.08
Total RNA-Seq data from leukemic patients with complex structural variants 0.07
RNAseq analysis of ruxolitinib treated breast cancers 0.05
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 0.05
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 0.05
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.05
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.05
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.05
Targeted enhancer activation by a subunit of the integrator complex 0.04
Characterization of the Merkel cell carcinoma miRNome 0.04
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.03
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.03
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 0.03
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.03
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.01
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.01
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.01
Toxoplasma gondii infection of human retinal pigment epithelial cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation